Toggle light / dark theme

But the technology for using bridge RNA in genome editing is still in the early stages. Hsu’s team has demonstrated this system only in bacteria, though Hsu says he is optimistic that efforts to adapt the approach to work in mammalian cells will succeed. Chen says this system’s efficiency may not be as good as CRISPR’s is now but that improvements will come with time.

The wearables market has been dominated, so far, by smartwatches and fitness trackers. The first Apple Watch was launched in April 2015, and wearable technology now includes jewelry that tracks your steps and notifies you of an incoming call, VR headsets for gamers, earbuds, smart glasses with Internet access, smart clothing integrated with electronic devices and a range of health monitors.

But the world’s first eyelid wearable device opens up a whole new world of opportunity.

Blink Energy’s device weighs just 0.4 grams (0.014 ounces) — less than half the weight of a paperclip – and is fitted to one eyelid. You barely notice it, says Bar-On. “After two minutes you forget it’s there.”

Electronic waste, or e-waste, is a rapidly growing global problem, and it’s expected to worsen with the production of new kinds of flexible electronics for robotics, wearable devices, health monitors, and other new applications, including single-use devices.

A new kind of flexible substrate material developed at MIT, the University of Utah, and Meta has the potential to enable not only the recycling of materials and components at the end of a device’s useful life, but also the scalable manufacture of more complex multilayered circuits than existing substrates provide.

The development of this new material is described in the journal RSC Applied Polymers (“Photopatternable, Degradable, and Performant Polyimide Network Substrates for E-Waste Mitigation”), in a paper by MIT Professor Thomas J. Wallin, University of Utah Professor Chen Wang, and seven others.

Researchers led by the University of California, Irvine have discovered how the TREM2 R47H genetic mutation causes certain brain areas to develop abnormal protein clumps, called beta-amyloid plaques, associated with late-onset Alzheimer’s disease. Leveraging single-cell Merfish spatial transcriptomics technology, the team was able to profile the effects of the mutation across multiple cortical and subcortical brain regions, offering first-of-their-kind insights at the single-cell level.

The study, published in Molecular Psychiatry, compared the brains of normal mice and special mouse models that undergo changes like those in humans with Alzheimer’s.

Findings revealed that the TREM2 mutation led to divergent patterns of beta-amyloid plaque accumulation in various parts of the brain involved in higher-level functions such as memory, reasoning and speech. It also affected certain and their gene expression near the plaques.

Non-personalized content and ads are influenced by things like the content you’re currently viewing and your location (ad serving is based on general location). Personalized content and ads can also include things like video recommendations, a customized YouTube homepage, and tailored ads based on past activity, like the videos you watch and the things you search for on YouTube. We also use cookies and data to tailor the experience to be age-appropriate, if relevant.

Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time.